Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Selecta Biosciences Inc Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 May 17, 2024	BUY	$1.04 - $1.4 $549,165 - $739,261	528,044 New	528,044 $591,000
Q4 2022 May 17, 2024	BUY	$0.96 - $1.6 $506,922 - $844,870	528,044 New	528,044 $596,000
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $702,298 - $1.37 Million	528,044 New	528,044 $865,000
Q2 2018 Aug 14, 2018	SELL	$9.36 - $13.25 $375,813 - $532,000	-40,151 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.49 - $11.82 $340,881 - $474,584	40,151 New	40,151 $409,000

Others Institutions Holding SELB

# of Institutions

Shares Held

4.67M

Call Options Held

Put Options Held

View Full List

About SELECTA BIOSCIENCES INC

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

More about SELB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account